**Operator:**
As it is time to start, we will now begin the Conference Call for the Presentation of the Financial Results for the Fiscal Year 2025 Second Quarter. Thank you very much for your participation.

Today, Mr. Sasaki, Representative Director and Senior Managing Executive Officer, will give a briefing on the financial results for fiscal year 2025 second quarter. Later, he will be joined by Mr. Yamauchi, Executive Officer and General Manager of Accounting Department to take questions. We will conclude the call at 4:50.

Mr. Sasaki, over to you.

—

**Keigo Sasaki**
Senior Managing Executive Officer of Corporate Communications, Accounting & Finance and Director

Thank you. I’m Sasaki from Sumitomo Chemical. Thank you very much for attending our conference call today despite your busy schedules.

I would like to express my sincere gratitude to our investors and analysts for your ongoing understanding and support of our management.

Now, let me start with the presentation of the financial results for the fiscal year 2025 second quarter. Please turn to Page 4.

This is a summary page. Core operating income and net income attributable to owners of the parent company have significantly improved compared to the same period last year.

Core operating income of Essential & Green Materials increased significantly year-over-year. Additionally, Sumitomo Pharma recorded profits driven by strong sales results, which contributed to overall sales growth.
https://seekingalpha.com/article/4837354-sumitomo-chemical-company-limited-sommy-q2-2026-earnings-call-transcript?source=feed_all_articles